These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27790761)

  • 1. Single-molecule force spectroscopy applied to heparin-induced thrombocytopenia.
    Nguyen TH
    J Mol Recognit; 2017 Mar; 30(3):. PubMed ID: 27790761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Single-Molecule Force Spectroscopy in Unraveling Typical and Autoimmune Heparin-induced Thrombocytopenia.
    Bui VC; Nguyen TH
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29614814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative description of thermodynamic and kinetic properties of the platelet factor 4/heparin bonds.
    Nguyen TH; Greinacher A; Delcea M
    Nanoscale; 2015 Jun; 7(22):10130-9. PubMed ID: 25981976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous binding of heparin and platelet factor-4 to platelets: further insights into the mechanism of heparin-induced thrombocytopenia.
    Horne MK; Hutchison KJ
    Am J Hematol; 1998 May; 58(1):24-30. PubMed ID: 9590145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epitope specificity of heparin-induced thrombocytopenia.
    Horsewood P; Warkentin TE; Hayward CP; Kelton JG
    Br J Haematol; 1996 Oct; 95(1):161-7. PubMed ID: 8857955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
    Prechel MM; Jeske WP; Walenga JM
    Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of the conformational changes in platelet factor 4 induced by polyanions: towards in vitro prediction of antigenicity.
    Brandt S; Krauel K; Gottschalk KE; Renné T; Helm CA; Greinacher A; Block S
    Thromb Haemost; 2014 Jul; 112(1):53-64. PubMed ID: 24671506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the interaction between platelet factor 4 and homogeneous synthetic low molecular weight heparins.
    Nguyen TH; Xu Y; Brandt S; Mandelkow M; Raschke R; Strobel U; Delcea M; Zhou W; Liu J; Greinacher A
    J Thromb Haemost; 2020 Feb; 18(2):390-398. PubMed ID: 31573759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
    Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D
    Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of heparin-induced thrombocytopenia (HIT) laboratory testing and the 4Ts scoring system in the intensive care unit.
    Pierce W; Mazur J; Greenberg C; Mueller J; Foster J; Lazarchick J
    Ann Clin Lab Sci; 2013; 43(4):429-35. PubMed ID: 24247801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.
    Cines DB; Rauova L; Arepally G; Reilly MP; McKenzie SE; Sachais BS; Poncz M
    J Clin Apher; 2007 Feb; 22(1):31-6. PubMed ID: 17285619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of anti-platelet factor 4/heparin antibodies depends on the thermodynamics of conformational changes in platelet factor 4.
    Kreimann M; Brandt S; Krauel K; Block S; Helm CA; Weitschies W; Greinacher A; Delcea M
    Blood; 2014 Oct; 124(15):2442-9. PubMed ID: 25150299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.
    Greinacher A; Gopinadhan M; Günther JU; Omer-Adam MA; Strobel U; Warkentin TE; Papastavrou G; Weitschies W; Helm CA
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2386-93. PubMed ID: 16873726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia.
    Fabris F; Luzzatto G; Stefani PM; Girolami B; Cella G; Girolami A
    Haematologica; 2000 Jan; 85(1):72-81. PubMed ID: 10629596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-induced thrombocytopenia: IgG binding to PF4-heparin complexes in the fluid phase and cross-reactivity with low molecular weight heparin and heparinoid.
    Newman PM; Swanson RL; Chong BH
    Thromb Haemost; 1998 Aug; 80(2):292-7. PubMed ID: 9716155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-transient "self-sustaining" heparin-induced thrombocytopenia: 4-year persistence of a platelet-activating PF4/heparin-antibody status without heparin exposure.
    Birschmann I; Gummert J; Schirmer U; Knabbe C; Sachs UJ; Koster A
    Platelets; 2014; 25(8):634-5. PubMed ID: 24246163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
    Visentin GP; Ford SE; Scott JP; Aster RH
    J Clin Invest; 1994 Jan; 93(1):81-8. PubMed ID: 8282825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
    Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
    Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-heparin/platelet factor 4 antibodies and heparin-induced thrombocytopenia--review].
    Lei Q; Chen L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):457-60. PubMed ID: 18426686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism and Clinical Presentation of Heparin-Induced Thrombocytopenia.
    Fischer KG
    Hemodial Int; 2001 Jan; 5(1):74-80. PubMed ID: 28452441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.